Efficacy and Safety of IQP-VV-102 in Weight Management

Double-blind, Randomized, Placebo-controlled, Bicentric Clinical Investigation to Evaluate the Safety and Efficacy of IQP-VV-102 in Reducing Body Weight in Overweight and Obese Subjects

Subjects are randomized to either IQP-VV-102 or a matching placebo. Over 12 weeks, the subjects' body weight, body fat and safety parameters are monitored

Inclusion Criteria:

• Age 18 to 60 years
• 25 kg/m2 ≤ BMI ≤ 35 kg/m2
• Written informed consent

Exclusion Criteria:

• Known sensitivity to sources of the active ingredients and excipients
• Pregnancy or nursing
• Inability to comply with study requirements, e.g. due to language difficulties
• Participation in another study during the last 30 days of the screening visit